Effectiveness of Systemic Administration of Amoxycillin and Metronidazole versus Azithromycin in Generalized Aggressive Periodontitis – A Randomized Controlled Clinical Trial
Journal Title: Journal of Pharmaceutical Research International - Year 2016, Vol 9, Issue 6
Abstract
Aim: To evaluate the effect of systemic Amoxycillin and Metronidazole against Azithromycin as an adjunct to non-surgical therapy and correlate the clinical periodontal parameters at baseline, 10 days and 30 days in subjects with generalized aggressive periodontitis (GAP). Study Design: Randomized controlled clinical trial. Place and Duration of the Study: The study was conducted in Saveetha Dental College and Hospitals from February 2015 to August 2015. Methods: Subjects were recruited from the outpatient department of Periodontics and were categorized as GAP according to AAP criteria. A total of 16 patients with GAP were included in the study. Clinical periodontal parameters like sulcus bleeding index [SBI], gingival index [GI], Probing depth [PD] and clinical attachment loss [CAL] were recorded at baseline. The subjects were then randomly allotted into Group 1 [Amoxycillin+Metronidazole] and Group II [Azithromycin]. After evaluation of clinical parameters at baseline, scaling and root planning [SRP] was done in both the Groups and systemic antibiotics, namely combination of Amoxycillin and Metronidazole in Group I and Azithromycin in Group II were administered. Subjects were recalled at day 10 and 30 for re-evaluation of clinical parameters. Within Group comparison was made using paired “t test” and inter Group comparison was made using Un-paired “t test”. Results: Intra-Group comparisons of clinical parameters between baseline and 30 days, in both the Groups were statistically significant (P<0.05). The difference from baseline to 30 days follow up in sulcus bleeding index (8.7±0.59 versus 4.1±0.38 mm) and clinical attachment loss (8.8±0.48 versus 4.6±0.39 mm) was statistically significant between the Groups (P<0.05). Whereas no statistical significance was found with gingival index and probing depth between the Groups (P>0.05). Conclusion: Systemic administration of Azithromycin as an adjunct to SRP in subjects with GAP resulted in better improvement of clinical periodontal parameters compared to a combination of Amoxycillin and Metronidazole.
Authors and Affiliations
Archana Mootha, Sankari Malaiappan, Sheeja S. Varghese, N. D. Jayakumar
Keywords
Related Articles
- EP ID EP342400
- DOI 10.9734/BJPR/2016/22732
- Views 78
- Downloads 0
Antidiabetic Activity and Toxicity Evaluation of Aqueous Extracts of Spondias mombin and Costus afer on Wistar Rats
Aims: To evaluate the antidiabetic efficacy of the aqueous extracts of Spondias mombin leaf and Costus afer stem, both individually and in combination ratios, as well as the acute and subchronic toxicities of the most ef...
Pharmacokinetic Characterization of Piperaquine in Nigerian Healthy Volunteers after Co-administration with a Commercial Brand of Moringa Tea
This 2-phase cross-over drug–herb interaction study investigated the effect of co-administration of tea prepared from the commercial product of Moringa oleifera on the pharmacokinetic parameters of piperaquine. Fourteen...
Synergistic Antibacterial Activity of Pleurotus Species (Mushroom) and Psychotria microphylla (Herb) against Some Clinical Isolates
Aims: This study investigated the synergistic antimicrobial activity of the extracts of Pleurotus species and Psychotria microphylla against five clinical bacterial isolates: Escherichia coli, Pseudomonas aeruginosa, Sal...
Anti-bacterial and in vitro Anti-diabetic Potential of Novel Isoxazole Derivatives
Aim: To synthesize novel Isoxazole derivatives, characterize them and subject for screening anti-bacterial action and in vitro anti-diabetic activity. Methodology: Chalcones were prepared by the reaction of aromatic alde...
Physicochemical and Bioequivalence Studies on Some Brands of Levofloxacin Tablets Registered in Nigeria
Aims: This study was aimed at comparing the physicochemical and bioavailability profiles of some brands of Levofloxacin 500mg tablets that are registered in Nigeria by her regulatory authority and to examine the feasibil...